Arecor

Developer of proteins, vaccines based on proprietary stabilization technologies for drug delivery

placeCambridge, England, United Kingdom calendar_todayFounded 2007 groups34 employees language arecor.com

Registered entities

Innovation

77 patent families (23 granted) — focus: Human necessities, Chemistry & metallurgy, Emerging technologies; filing pace slowing. Cited 1,742 times.

YearFilings
20155
20168
201710
201819
201919
202021
202112
202214
202319
202413
202514
20263

Social engagement

Social engagement: 4.1K social following, 9 posts in the last 12 months — around the industry typical range.

Investor mix

11 investors on record; lead investors include Albion Capital Group, Calculus Capital, Downing.

Investor typeCountShare
Venture capital545%
Private equity19%
Angel & family office19%
Other / undisclosed436%

Recent activity

16 Jun 2026
Event
BIO International Convention 2026
4 Jun 2026
Event
ADA26
19 May 2026
Event
American Diabetes Association Scientific Sessions 2026
Coming soon